Home › Stocks › DCOY

DCOY — DECOY THERAPEUTICS INC

Reported value held$139.29K
Funds holding (latest)17
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)6
Institutional value$87.65K · 44.48K sh
New / Add / Cut / Exit3 / 2 / 0 / 1 · Updated 2026-11-16
Top-5 / Top-10 concentration99.8% / 100.0%
Institutional holdings change Accumulating +184.9% (+7.98K sh)
Institutional value change Down -21.9%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
$535,059 — -$7.2M — -158.2% — -971.9% — — — —

Net margin trend

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingBuy
Analysts covering—
12-month price target$3.00 (+223.5%)
Last price at fetch$0.93
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)—
Revision score (year)-1.00
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -11.34 — -11.34 -11.34 1 −1
Dec 2027 -9.46 — -9.46 -9.46 1 −1
Dec 2028 -16.49 — -16.49 -16.49 1 —

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 6 SEC-registered investment managers reported holding DCOY (DECOY THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $87.65K across 44.48K shares. That is +184.9% by share count (+7.98K shares) versus the previous quarter, while reported value moved -21.9%. Ownership is concentrated: the five largest holders account for 99.8% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 3 opened new positions, 2 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of DECOY THERAPEUTICS INC (DCOY) include COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, StoneX Group Inc., ranked by reported 13F value among the 17 institutional holders on this page.

DCOY is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 6 44.48K $87.65K +184.9%
Q2 2026 4 4.32K $31.04K -82.1%
Q1 2026 4 1.61K $10.51K -83.2%
Q4 2025 9 79.25K $51.43K +13300.0%
Q3 2025 5 537 $1.98K —
Q3 2023 1 1.80K $6.00K —

Over the 6 quarters shown, institutional share counts increased 2371% in aggregate (Q3 2023 → Q3 2026); the largest single-quarter swing was Q4 2025 (+13300.0%).

Top Institutional Holders (Q3 2026) — 6 funds

FundSharesValuePortfolio WeightChange
COMMONWEALTH EQUITY SERVICES, LLC 32.00K $63.04K 0.00% New
UBS Group AG 4.53K $8.91K 0.00% Add
VANGUARD CAPITAL MANAGEMENT LLC 4.03K $7.95K 0.00% Hold
Tower Research Capital LLC (TRC) 3.73K $7.36K 0.00% Add
SBI Securities Co., Ltd. 111 $219 0.00% New
JPMorgan Chase & Co 80 $170 0.00% New

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 4 funds

FundSharesValuePortfolio WeightChange
VANGUARD CAPITAL MANAGEMENT LLC 4.03K $29.00K 0.00% New
Tower Research Capital LLC (TRC) 256 $1.84K 0.00% Reduce
UBS Group AG 25 $180 0.00% Reduce
Caitong International Asset Management Co., Ltd 2 $14 0.00% New

Q1 2026 — 4 funds

FundSharesValuePortfolio WeightChange
Tower Research Capital LLC (TRC) 1.02K $6.67K 0.00% Reduce
UBS Group AG 546 $3.57K 0.00% Reduce
Advisory Services Network, LLC 41 $268 0.00% New
Morgan Stanley 1 $7 0.00% New

Q4 2025 — 9 funds

FundSharesValuePortfolio WeightChange
Warberg Asset Management LLC 28.00K $18.18K 0.00% New
StoneX Group Inc. 19.99K $12.97K 0.00% New
XTX Topco Ltd 10.94K $7.10K 0.00% New
Geode Capital Management 10.92K $7.08K 0.00% New
UBS Group AG 4.92K $3.19K 0.00% Add
Tower Research Capital LLC (TRC) 4.44K $2.88K 0.00% New
Bank of America Corp 36 $23 0.00% Add
DANSKE BANK A/S 1 $1 0.00% Hold
OSAIC HOLDINGS, INC. 3 $1 0.00% Hold

Q3 2025 — 5 funds

FundSharesValuePortfolio WeightChange
Advisory Services Network, LLC 500 $1.83K 0.00% New
UBS Group AG 29 $106 0.00% New
OSAIC HOLDINGS, INC. 3 $17 0.00% New
Bank of America Corp 4 $15 0.00% New
DANSKE BANK A/S 1 $4 0.00% New

Q3 2023 — 1 funds

FundSharesValuePortfolio WeightChange
SIMPLEX TRADING, LLC 1.80K $6.00K 0.00% New

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 17 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q3 2023
COMMONWEALTH EQUITY SERVICES, LLC 32.00K — — — — —
UBS Group AG 4.53K 25 546 4.92K 29 —
VANGUARD CAPITAL MANAGEMENT LLC 4.03K 4.03K — — — —
Tower Research Capital LLC (TRC) 3.73K 256 1.02K 4.44K — —
SBI Securities Co., Ltd. 111 — — — — —
JPMorgan Chase & Co 80 — — — — —
Warberg Asset Management LLC — — — 28.00K — —
StoneX Group Inc. — — — 19.99K — —
XTX Topco Ltd — — — 10.94K — —
Geode Capital Management — — — 10.92K — —
SIMPLEX TRADING, LLC — — — — — 1.80K
Advisory Services Network, LLC — — 41 — 500 —
Bank of America Corp — — — 36 4 —
OSAIC HOLDINGS, INC. — — — 3 3 —
Caitong International Asset Management Co., Ltd — 2 — — — —
Morgan Stanley — — 1 — — —
DANSKE BANK A/S — — — 1 1 —

Download holders (CSV)

FAQ

Which funds hold DCOY?

As of 2026-Q3, 6 institutional funds reported holding DCOY (DECOY THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $87.65K.

How many shares of DCOY do institutions own?

13F filers reported 44.48K shares of DCOY, worth $87.65K in aggregate at the end of 2026-Q3.

Is institutional ownership of DCOY rising or falling?

Share counts moved +184.9% versus the prior quarter — accumulation.

Who are the top institutional holders of DCOY?

The largest 13F holders are COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, StoneX Group Inc., UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of DECOY THERAPEUTICS INC?

The major shareholders of DECOY THERAPEUTICS INC (DCOY) by reported 13F value are COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, StoneX Group Inc., UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC, among 17 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own DCOY" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/DCOY/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →